OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

FINANCIAL STATEMENTS 31 DECEMBER 2023

Charity Number 1062067

COMPANY REGISTRATION NUMBER 03337359

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

CONTENTS PAGE
Trustees’ Annual Report 3
Independent auditor's report to the members 20
Statement of financial activities (incorporating the
income and expenditure account) 24
Balance sheet 26
Statement of cash flows 27
Notes to the financial statements 28
The following pages do not form part of the financial statements
Detailed statement of financial activities 45

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

REFERENCE AND ADMINISTRATIVE DETAILS

Trustees and Directors

For the purposes of charity and company law and in accordance with the Association’s governing document, the trustees of the charity and the directors of the company are certain executive officers of the Council of the Association. The trustees and directors that have held office since 1 January 2023 are as follows:

Miss Daljit K Dhariwal President (from 1 July 2023) Vice President (to 30 June 2023)

Professor Cyrus J Kerawala Immediate Past President ( from 1 July 2023 ) President (1 July 2022 to 30 June 2023) Professor Kathleen Fan Vice President (from 1 July 2023) President Designate (to 30 June 2023) Mr Robert J Banks Honorary Treasurer (appointed 1 January 2022) Miss Kanwalraj Moar Honorary Secretary and Company Secretary (appointed 1 January 2022 resigned June 2023) Mr Iain Varley Honorary Secretary and Company Secretary (appointed 1 July 2023)

The Council of the Association

The trustees and directors are assisted and advised by the other officers and members of the Council of the Association, who have held office since 1 January 2023, as follows:

Officers of Council

Mr Patrick Magennis President Designate (from 1 July 2023 to 30 June 2024) Mr Kaveh Shakib BJOMS Editor (appointed from 1 January 2019) Professor Peter A Brennan Chair of Council (from 1 January 2020)

Members of Council

Miss Nabeela Ahmed (from 1 January 2022) Mr Alexander Goodson (from 1 January 2021) Miss Anne Begley (from 1 January 2022 re-elected) Miss Elizabeth Gruber (from 1 January 2022) Mr Dilip Srinivasan (from 1 January 2023) Professor Carrie Newlands (from 1 January 2022) Miss Harpreet Ark Associate Fellow (from 1 January 2022) Miss Jennifer Parrish Associate Fellow (from 1 January 2022) Mr Suresh Shetty Consultants and Specialists’ Group Chair (from 1 October 2021)

- 3 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

REFERENCE AND ADMINISTRATIVE DETAILS (continued)

Members of Council (continued)

Mr David J W Keith Consultants and Specialists’ Group Deputy Chair (from 1 October 2021) Ms Sirisha Duggineni Fellows in Training Representative (from 1 January 2023) Mr Adam Holden Deputy Fellows in Training Representative (from 1 January 2023) Ms Danielle Britton Junior Trainees and Members’ Representative (from 1 January 2023) Mr Richard Taylor Deputy Junior Trainees and Members’ Representative (from 1 January 2023)

The principal address of the charity and the registered office of the company is the offices of the Association at The Royal College of Surgeons of England, 38/43 Lincoln’s Inn Fields, London WC2A 3PE.

The charity is registered under the charity number 1062067, and the company is incorporated with the company registration number 03337359.

The trustees have made the following professional appointments:

Accountant: Hardcastle Burton Chartered Accountants, 36 Dene Road, Northwood, Middlesex HA6 2DA Auditor: Buzzacott LLP, 130 Wood Street, London EC2V 6DL Bankers: Lloyds TSB Bank plc, Kings Cross Branch, 344 Gray’s Inn Road, London WC1X 8BX CCLA Investment Management Limited, 80 Cheapside, London EC2V 6DZ Investment Manager: Cazenove Capital Management wealth management from Schroders, 12 Moorgate, London EC2A 6DA Solicitor: Hempsons London, Hempsons House, 40 Villiers Street, London WC2N 6NJ

The following key members of staff are responsible for the day-to-day management of the charity:

Ms Sarah Durham Senior Administrator Mrs Dannielle Bellanca Assistant Administrator

- 4 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT

The trustees present their report and the financial statements of the British Association of Oral and Maxillofacial Surgeons (“The Association” or “BAOMS) for the year ended 31 December 2023. The financial statements have been prepared in accordance with the accounting policies set out on pages 28 to 32 of the financial statements and comply with the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applying to charities preparing their accounts in accordance with the Financial Reporting Standard in the United Kingdom and Republic of Ireland (FRS 102).

Status and History

BAOMS is a registered charity, and a company limited by guarantee, not having share capital. Every member undertakes to contribute an amount not exceeding £1 to the assets of the charity in the event of the charity being wound-up during the period of membership, or within one year thereafter.

Oral and Maxillofacial Surgery originated in the United Kingdom as the surgical specialty of dentistry, developing from the need for specialist services to treat jaw injuries sustained by servicemen during the two World Wars. It soon became clear that the prevalence of civilian facial injuries in peace time was at least as great, largely due to the increasing use of motor cars and motorcycles.

The specialty of Oral and Maxillofacial Surgery evolved to meet the clear demand for treatment of an increasingly large range of pathological conditions of the face, jaws and teeth. The complexity of the specialty was reflected by a change of title from The British Association of Oral Surgeons to The British Association of Oral & Maxillofacial Surgeons in the year ended 30 June 1986.

The specialty Association was incorporated on 21 March 1997 and became a registered charity on 24 April 1997. BAOMS is governed by the rules and regulations set down in its company Memorandum and Articles of Association as last updated on 8 October 2021.

Organisational Structure and Key Management

The overall strategic direction of the charity is determined by the trustees, who are assisted and advised by the other officers and members of the Council of the Association.

The Council normally has 18 members, but additional individuals will be co-opted to attend for specific relevant matters. The Council meets four times a year. The Council members outside Chair, Deputy Chair and the Editor receive no remuneration for their work carried out on behalf of the Association. Travel expenses are paid for all members of Council, who carry out work on behalf of the Association on various committees and working parties in the United Kingdom and throughout Europe.

A Chair of Council is appointed by Council and holds office for a term of four years. The incumbent chairs the Council meetings and represents the Association on a number of committees. The role of Chair of Council is non-voting. The Chair of Council shall be appointed in the first instance as Deputy Chair of Council for a period of one year to run in parallel with the last year of office of the out-going Chair of Council.

- 5 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Organisational Structure and Key Management (continued)

The trustees consider that they, together with the Chair of Council and the Senior Administrator, comprise the key management of the charity in charge of directing and controlling, running and operating the charity on a day-to-day basis.

The Chair of Council, being a paid role, is remunerated by the Association to the equivalent of two Programmed Activities (units of paid clinical time in the NHS), the equivalent of one working day per week on basic salary. This amount is paid direct to the employing Trust or Organisation in recognition of clinical time spent on Association business. The Deputy Chairman (when in post) is normally remunerated with half a working day per week, again based on basic salary, and paid to their employing NHS Trust.

The day-to-day administration of the Association is carried out by Ms Sarah Durham, the Senior Administrator and Ms Dannielle Bellanca as Assistant Administrator.

Office space is rented from and based at the Royal College of Surgeons of England. Additional facilities, such as Human Resources advice, are ‘bought in’ from the Royal College of Surgeons of England, as and when the need arises. Post pandemic the office team have continued to work in the office and from home.

Daily correspondence is dealt with by the office staff and copies are circulated to the trustees and/or the Chair of Council, as appropriate, for comment and dissemination to Council as required. A detailed work plan is agreed annually between the Senior Administrator and the trustees, which sets out the major aims and activities for each year.

The Association’s key goals (such as maintaining funding for the Research Fund) are constant factors in any given year. Other factors include:

Council appoints a number of sub-committees to organise different areas of the Association’s activities as detailed below:

- 6 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Organisational Structure and Key Management (continued)

In addition, Council spearheads initiatives relating to other education and research issues, public awareness and general promotion of the Specialty - as these are the central main objectives of the charity.

Method of Recruitment, Appointment, Election, Induction and Training of Trustees

Recruitment

Trustees are selected from past and present Council members (excluding retired Council members). The Honorary Secretary and the Honorary Treasurer may be recruited from the Fellows category of membership. An outline of the duties for each of the trustee positions is circulated to the relevant members of the Association.

Nominations are then submitted together with a supporting statement from the applicant. These are then considered and a trustee appointed at a Council meeting at least three months prior to the post becoming vacant.

Appointment and Election

Under the requirements of the Memorandum and Articles of Association, the members of Council are elected to serve for a period of three years. All eligible fellowship categories of the Association are circulated with an outline of the duties required and nomination forms are submitted along with a statement of intent, which is included with an online election and then circulated to eligible voting members of the Association. Following a change to the Memorandum and Articles of Association in October 2021, the Presidential handover/Term of office was changed from 1 January to 31 December to 1 July to 30 June to allow for the handover to take place at the Annual Scientific Meeting of the Association which is usually in June/July.

Induction and Training

Having accepted appointment, trustees are sent the main documents, which set out the operational framework of the Association, including the Memorandum and Articles of Association. In addition, trustees are directed to the Charity Commissions’ guide ‘the Essential Trustee’. On-going training for trustees is organised and provided by the Association as and when required. Demitting officers / trustees are encouraged to advise and inform new appointees where practicable.

- 7 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Risk and Corporate Governance Matters

The trustees have reviewed the major risks facing the Association, aiming to minimise the charity’s exposure to risk, whilst attending to its viability and ensuring its longevity. The management of risk is the responsibility of the whole board of trustees, who monitor exposure through regular contact with Council members and office staff. The Association carries a range of insurances, renewed annually, to cover the key insurable risks associated with the administration of the charity’s activities, and office procedures ensure that daily back-ups are run for all of the Association’s data, including information published on the website.

The trustees consider the key risk facing the Association to be loss of membership. If this were to happen on any significant scale, there would be no reason for the Association to continue in existence and no meetings would need to take place. They constantly review the incentives and recruitment initiatives to engage as many practitioners of OMFS as possible in Association membership categories. The Association also has a risk register which is reviewed and updated annually.

Statement of Trustees’ Responsibilities

The trustees (who are also the directors of The British Association of Oral and Maxillofacial Surgeons for the purposes of company law) are responsible for preparing the trustees’ annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the trustees to prepare financial statements for each financial year. Under that law, the Trustees have prepared financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

Under company law, the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company, and of the income and expenditure, of the charitable company for that period.

In preparing those financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records that are sufficient to show and explain the charitable company’s transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

- 8 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Statement of Trustees’ Responsibilities (continued)

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from the legislation in other jurisdictions.

Auditor

Following a tendering process Buzzacott were appointed as the auditors in the year ended 31 December 2015 – for an agreed period of three years to be reviewed at expiry. At a Council meeting held on 19 June 2018 it was agreed to extend the appointment of the auditors for a further three year period with the next review scheduled for 2024 .The auditors were re-appointed at the Annual General Meeting held on 28 June 2023.

Statement as to Disclosure of Information to the Auditor

The trustees at the date of approval of this trustees’ annual report confirm that so far as each of them is aware, there is no relevant audit information of which the charity’s auditor is unaware, and the trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.

Professional Indemnity Insurance

The charity has taken out a public liability insurance policy that provides professional indemnity cover (amounting to £500,000 in respect of any one claim) for the Council members (including the trustees) and the staff of the charity. The cost of this insurance policy to the charity for the year was £1,548 (2022: £1,483).

OBJECTIVES AND ACTIVITIES

Charitable Objectives

The charitable objectives for which the charity is established are as follows:

- 9 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

OBJECTIVES AND ACTIVITIES (continued)

Charitable Activities

In order to meet its charitable objectives, the trustees have set an overall goal for the Association to do everything within it powers to promote and encourage education, study, research and development of Oral and Maxillofacial Surgery as a specialty.

In pursuance of its overall goal, the Association’s principal activity is the dissemination of information as it relates to the specialty.

Each year this activity is undertaken in a number of ways, including:

Indicators, Milestones and Benchmarks

The trustees monitor a range of measures by which to try to determine the success of the charity in meeting its objectives. These measures include:

Public Benefit

The trustees have taken the Charity Commission’s general guidance on public benefit (contained within the recently revised guidance publication “Charities and Public Benefit”) into consideration in preparing their statements on public benefit contained within this trustees’ annual report.

Benefits and Beneficiaries

In accordance with its charitable objectives, the Association strives to promote education, study, research and development of Oral and Maxillofacial Surgery. In doing so, BAOMS seeks to improve the quality of medical care for the benefit of patients. The charity’s ultimate beneficiaries are therefore patients, and benefits to patients are provided through advancing knowledge of, practice in and standards for the specialty.

- 10 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

OBJECTIVES AND ACTIVITIES (continued)

Public Benefit (continued)

Trustees’ Assessment of Public Benefit

In relation to the assessment of public benefit, the trustees monitor the public benefits which are delivered through the training and support of Oral and Maxillofacial Surgeons (OMFS) within the NHS and interface with individual hospital units. The Association is represented on a number of committees (see pages 11 and 12) to ensure that there are a sufficient number of OMFS consultants to serve the public need.

There is also a direct interface with the public via the Association’s website which includes advice leaflets and information about the specialty, information on NHS hospital units and also careers advice.

Grant Making Policy

The Association finances a number of awards to support education and research. These are as follows:

Down Surgical Prize Norman Rowe Lecture Prize BAOMS Surgery Prize Norman Rowe Clinical Prize Paul Toller Research Prize Junior Trainees and Members’ Prize Associate Fellows Prize Clinical and Research Poster Prizes IMP Technicians Lecture Prize Trainers’ Prizes BJOMS Prizes

The Endowments Sub-Committee (which is appointed by and from Council) meets twice a year to consider applications for research and clinical placement grants. The sub-committee recommends candidates for prizes and grants to Council and advises on the distribution of available funds.

There are prizes available to all categories of membership. Full information on the application process can be found on the BAOMS website (www.baoms.org.uk).

In addition, the Association offers student bursaries to second degree students (studying for their BDS or MBBS) who are interested in pursuing a career in Oral and Maxillofacial Surgery, together with complimentary membership of the Association where applicable and subsidised attendance fees for the Annual Scientific Meeting. Free membership and subsidised attendance rates at the ASM are also now available to first degree students with an interest in the specialty.

- 11 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

OBJECTIVES AND ACTIVITIES (continued)

Research and Travel Grants

Grants are made available to suitable and successful applicants in respect of: Significant Research Grants Major Travel Grant Trainees Travel / Study Grants Support for Specialty Meetings Small Project Grants (priming simple research projects and also mini travel grants) Student Bursaries and Student Electives

Application details are available on the Association’s website at www.baoms.org.uk

Representation on Other Bodies

The specialty of Oral and Maxillofacial Surgery is represented on the following:

British Association of Surgical Oncology (BASO) Confidential Reporting System in Surgery (CORESS) Federation of Surgical Specialist Associations (FSSA) The Royal College of Surgeons (RCS) of England Council Specialty Advisory Committee (SAC) in Oral and Maxillofacial Surgery Specialty Advisory Committee (SAC) in Oral Surgery Senate of Dental Specialties Intercollegiate Board: (FRCS) RCS Trauma Committee RCS Cancer Services Committee RCS Revalidation Board Royal College of Surgeons of Edinburgh Board European Association of Cranio and Maxillo Facial Surgeons (EACMFS) Council European Reference Network for rare diseases UEMS Monospecialty Section in Stomatology and Oral and Maxillofacial Surgery International Association of Oral and Maxillofacial Surgeons (IAOMS) BMA: CCSC Surgical Specialties Sub-Committee Department of Health Professional Bodies

The Chairman of Council represents the Association at the majority of the meetings of the organisations outlined above. If the Chairman of Council (or Deputy Chairman) is unable to attend, where possible, an alternative representative is selected from current Council members. Reports are provided to Council following each meeting. It is vital to have a working relationship on these professional bodies to achieve the overall aims of the Association at local, national and international level.

- 12 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

ACHIEVEMENTS AND PERFORMANCE

Activities, Events and their Impact

The Association has been active in a number of areas:

BJOMS:

BJOMS: The Association continued to organise the publication of The British Journal of Oral and Maxillofacial Surgeons (“BJOMS”), which is the official publication of the Association, through the editorial team. Members are encouraged to submit articles on Oral and Maxillofacial Surgery for publication in BJOMS. The Journal Editorial Board is managed by the Editor and the Honorary Treasurer and meets several times a year. The Editor prepares a report for each Council meeting and for the Annual General Meeting. The Journal (10 issues per year) is currently published in conjunction with Elsevier on a five-year contract. Following a review and process carried out by the Editor and reported at a Council meeting the current publishers, Elsevier, were reappointed and a new five-year contract (2023 to 2027 was agreed and signed). The BJOMS Editor continues to oversee the journal during the term office which is currently a five-year term (since 2019).

In 2020 as one of the strategic aims of the Association, Mr Kaveh Shakib, BJOMS Editor, proposed a second journal, “Advances in Oral and Maxillofacial Surgery” (ADOMS) which is a new open access journal dedicated to publishing research articles on all aspects of surgery in the oro-facial and head and neck region. The ADOMS continues to publish original research, review articles, editorials, technical notes and case reports thus helping to create access for Junior Trainees wishing to publish, whilst maintaining the impact factor for BJOMS.

Both BJOMS and the sister Journal ADOMS continue to function well and Kaveh and the editorial team are to be congratulated for their delivery of both journals on behalf of BAOMS. Kaveh Shakib demits from the Editor role after a successful 5-year term and thanks extended to him from the Trustees, BAOMS Council and wider Association. As the current deputy, Professor Panos Kyzas will take over the Editorial role from 1 January 2024 and Mr Rabin Singh will take on the deputy role. Both are 5-year terms.

Report from BAOMS Quality and Outcomes in Oral and Maxillofacial Surgery (QOMS), Dr Fabien Puglia, QOMS Project Manager

Twenty-three hospitals across England, Wales and Scotland have contributed to the registries in QOMS. Over the past year, the OMFS teams from Eastbourne, Dundee, Carlisle, Northampton, Derby and York have joined the initiative. We have now collected over 8000 patient episodes of treatment in REDCap across our 6 core audits. This would not be possible without all the data coordinators and surgeons participating to the project. Thank you all. Reporting outcomes remains at the forefront of the project. We published in February 2023 (revised in October 2023) the first QOMS report for the 2021-2022 period. Preliminary comparative data for outcomes in relation to the quality indicator metrics in the Oncology, Reconstruction and Non-Melanoma Skin Cancers registries were included in the report. In reporting of flap reconstruction outcomes in the Oncology & Reconstruction registry, we have specifically developed a Cumulative Sum (CuSUM) chart module for flap outcomes with Queen Mary University of London that plots longitudinally flap outcomes and associated risks in a CuSUM chart.

There has been ongoing development in the design of dashboards for users. We have recently added a Morbidity and Mortality 2022 vs 2023, and a new Head and Neck GIRFT review dashboard is to be released by the end of 2023. Please contact us if you have any suggestions for new dashboards or to improve existing ones.

- 13 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

ACHIEVEMENTS AND PERFORMANCE (continued)

NEW CONTENT IN QOMS

Following the publication of the QOMS report, the content of the Trauma, NMSC and Oral and dentoalveolar registries were updated. We have made progress on the development of two new registries. The Salivary Gland Cancers registry was launched in October 2023 and the Rare Benign Lesions of the Jaws registry is due to be launched in December 2023, both were recently presented in the “Remembering Rare Diseases” day at the House of Lords, hosted by the Head and Neck Cancer Foundation (Professor Mark McGurk and team). A new set of PROM for orthognathic surgery has been agreed and is currently being piloted at two hospitals. This new BAOMS BOS Orthognathic PROM is a collaboration with the British Orthodontic Society (BOS). We have developed two add-on modules for the QOMS Oncology & Reconstruction registries. One will capture outcomes for patient-specific implants for mandible reconstruction and the “Restorative dentistry / Oral rehabilitation for oncology patients” module will assess the timeliness of restorative dentistry services in the treatment of patients affected by oral / head and neck cancers.

Participation to QOMS is open to every OMFS department in the UK. Engagement welcomed from all OMFS units and the level of contribution can be tailored to the scope of each unit’s practice. Please contact us for more information: baomsprojectmanager@baoms.org.uk

BAOMS QOMS Executive Team: Clinical Lead: Mr Michael Ho, Deputy Clinical Lead: Mr David Tighe, Project Manager: Dr Fabien Puglia. Find out more about QOMS in our newly updated webpages.

BAOMS Website: www.baoms.org.uk

The website continues to provide a useful resource for the public with online patient advice information and a facility to search for oral and maxillofacial surgeons by special interest. There are various discussion forums for BAOMS members, which are hosted in the members’ secure area.

The Flex Facs online educational resource project continues to be available and on the site.

BAOMS Office and membership support

The BAOMS office team continue to work in the BAOMS office at the Royal College of Surgeons of England as well as from home. Supporting the membership with frequent website updates as well as assisting with general membership queries. The day the day to day running and management of the Association is under the direction of the Senior Administrator and Chair of Council.

Presidential Annual Fund

This year’s Presidential initiative is patient centred, for awards that impact patient care, information and involve patient collaboration. Successful applicants have been awarded funds to develop their ideas which they will showcase at the annual scientific meeting in Oxford in July 2024 hosted by the BAOMS 62[nd] President, Miss Daljit K Dhariwal.

Online Book Dental Students, led Ms Nabeela Ahmed, Council member

Following on from the success of the online Book “Oral and Maxillofacial Surgery – An Illustrated Guide for Medical Students and Allied Healthcare Professionals”, a version for Dental Healthcare Professionals was developed during 2023 and planned to be launched in 2024.

- 14 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

ACHIEVEMENTS AND PERFORMANCE (continued)

Activities, Events and their Impact

BAOMS 2023 Annual Scientific Meeting (ASM) and other meetings Report of the 2023 BAOMS ASM, 28-30 June 2023, Hosted by BAOMS 61[st] President, Professor Cyrus J Kerawala

This year the BAOMS ASM was held in London at Kings Place from 28-30 June 2023 with a theme of Health and Wellbeing. During the meeting, the BAOMS AGM and Awards Ceremony took place on Wednesday 28 June and the Presidential handover, on Friday 30 June at the end of the conference. The main scientific programme included Mr Peter Duffy MBE, who presented the President’s Lecture entitled: NHS Whistleblowing – a personal experience. The Norman Rowe Lecture was delivered by Mr Simon Fleming entitled: Challenging Culture. There was a variety of themed sessions over the three days which included ‘Things I wish I’d known before… I started a research career; I became a consultant oral surgeon’ and a session on overcoming adversity. There were also three Question Time styled sessions on skin cancer, research and orthognathic surgery and presentations on interests outside surgery: Animal husbandry, Sculpture and Wildlife Photography. There were 72 free papers which ran in parallel to the keynotes and symposia over all three days and there also 152 ePoster abstracts. The Top 10 posters were on display on site during the meeting. All accepted abstracts are published online in BJOMS. There was a welcome reception around the medical exhibition on Wednesday 28 June. The Annual Dinner, on Thursday 29 June was held at the Great Hall in Lincoln’s Inn with the usual after dinner toasts and dancing to a live band. There were three premium event sponsors: KLS Martin, DePuy Synthes and Stryker along with other exhibiting companies. BAOMS are grateful for their support of the BAOMS ASM. There was also a conference app which was well received. Total overall onsite attendance in 2023 were 450 over the three-day event at Kings Place close to Kings Cross St Pancras in North London.

Report of the 2023 Junior Trainees Conference held 11/12 November 2023, Mr Richard Taylor, 2023 Junior Trainee Group (JTG)

The JTG annual conference ran 10 -12[th] 2023 November in Sheffield. This was extremely successful with a record attendance of 176 delegates.

Friday 10th November Pre-conference day : On the Friday, there was a “pre-conference course” with a full day programme themed around head and neck cancer. This limited course had 15 attendees and included 3 sessions each delivered by consultant faculty: 1) Airway masterclass: front of neck access, airway assessment, flexible nasoendoscopy. 2) Fibula masterclass: planning of mandibular reconstruction, planning dental rehabilitation, plate bending. 3) Microsurgery masterclass: microsurgical anastomosis: end to end, end to side, nerve repair.

11th & 12th November - Main conference: The venue for the main conference was the Mercure St Pauls hotel in central Sheffield. Generous industry sponsorship in addition to a grant from BAOMS contributed to this being an extremely high-quality event promoting the specialty. Over 140 delegates were allocated places on the handson workshops over the course of the weekend including trauma plating workshops and skin cancer workshops. 150 delegates joined us for the annual JTG gala dinner, hosted at the Mowbray .

Report of 2023 Fellows in Training conference 2023, London on 27 June 2023

Ms Sirisha Duggenini and Mr Adam Holden, 2023 Fellows in Training representatives on BAOMS Council

The Fellows in Training held a successful conference held in London at the RCGP in Euston Square, London on 27 June 2023 with 49 trainees attending in person and a further 5 attending virtually.

- 15 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

ACHIEVEMENTS AND PERFORMANCE (continued)

Activities, Events and their Impact (continued)

Report from Consultants’ and Specialists Group (CSG) Study Day 7 December 2023

Mr Suresh Shetty, Consultants and Specialist Group Lead and Mr David Keith, Consultants and Specialist Group Deputy

The CSGs held a successful study day on Thursday 7 December in London at the Honourable Society of Lincoln’s Inn. There were a total of 45 attendees and the programme theme was Private Practice for the future.

BAOMS Flex Facs

FlexFacs continues to be the BAOMS innovative, online training and educational resource for speciality trainees in oral and maxillofacial surgery (OMFS), launched by the British Association of Oral and Maxillofacial Surgeons (BAOMS) in 2021. There are monthly one hour masterclasses on all aspects for the OMFS curriculum. The Flex Facs resource pages are available to all members in the BAOMS members’ area. Many thanks go to the leads Mr Montey Garg and Mr Micheal Nugent who manage the arrangements.

FINANCIAL REVIEW

Financial Results of Activities and Events

During 2023, the Association generated £1,205,285 (2022: £862,805) of income, and expended resources of £950,053 (2022: £943,071) principally disseminating information as it relates to any and all of the fields that pertain to the Association’s charitable objectives.

In particular, 2023 Annual Scientific Meeting resulted in a deficit of £3,197 (2022: surplus of £47,496) and the British Journal of Oral and Maxillofacial Surgery plus the Advances in Oral and Maxillofacial Surgery contributed a surplus of £171,815 (2022: £203,894). A significant proportion of Journal income arose from paid electronic downloads of content – from around the globe, demonstrating the breadth of appeal of the material presented. Net investment gains in the year were £33,999 (2022: losses £154,635), resulting in a net increase in funds of £289,051 (2022: decrease £234,901).

Grant Making

In 2023, grants totalling £42,856 (2022: £76,834) were allocated during the financial year to members of the Association for research projects and travel to centres of excellence overseas.

The Association continues to support bursaries for medical students completing their double degree as part of the relatively long training programme for the specialty. In 2023, £34,250 was awarded to thirty one individuals (2022: £32,000 was awarded to thirty four individuals).

- 16 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

FINANCIAL REVIEW (continued)

Reserves Policy

When considering the need for free reserves the trustees are mindful that they must put in place a suitable foundation for the charity to achieve its long-term strategic goal, that being for the work of the Association to be continued in perpetuity. In addition, the trustees have identified the following areas in which expenditure will be required soon:

In addition to the day-to-day work of the Association the following and on-going areas have been identified in 2023

Up to £12,500 for the speakers’ educational fund to fund educational lectures at the Annual Meeting

£100,000 for research and clinical / mini grants;

£15,000 to provide complimentary membership of the Association to students studying their second degree;

£10,000 to provide complimentary registration at the ASM for students studying for their first and second degrees;

£30,000 (up to £40,000) to provide student bursaries/support to students studying their second degree;

£15,000 to support the junior trainees programme, ASiT membership and recruitment

£15,000 venue deposits for future meetings;

£10,000 for updates to the website on-going

£5,000 for on-going hosting (£1,000 pcm), support and development of the website (Light Media) to continue to increase its educational and interactive capacity and to further widen communication with the membership;

£10,000 support costs for membership application system (Oomi)

£25,000 for the President’s Annual Fund

£75,000 QOMS Project manager and audit registry

Reserves Policy

Bearing this in mind the trustees consider that, in order to limit financial risk and based on current staffing levels, the level of free reserves should be equal to £500,000. This will allow the capacity to operate the work of the Association effectively in the event of unforeseen financial difficulties. It is expected that this would be sufficient to cover the operational costs of the Association for a period of nine months.

Financial Position

The total ‘unrestricted funds’ of the charity as at 31 December 2023 amounted to £1,362,294 of which £823,262 had been allocated to the Designated Research Fund (31 December 2022: £1,471,028 of which £1,234,912 had been allocated to the Designated Research Fund) and £14,064 (2022: £21,096) relates to the remaining net book value of fixed assets, and therefore do not form part of the free reserves. The free reserves of the charity as of 31 December 2023 therefore amounted to £539,032 (2022: £236,116)., and include a £500,000 transfer from the

- 17 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

FINANCIAL REVIEW (continued)

Financial Position (continued)

Designated Research Fund following the Trustees’ decision to release designated funds that were held surplus to requirements.

Investments Policy

The trustees have wide ranging powers to invest the funds of the Association as they see fit, and in practice, they receive advice from the Association’s investment managers on appropriate investments. The Association’s investment portfolio is now managed by Cazenove Capital Management wealth management from Schroders.

BAOMS uses a Responsible Multi-Asset Fund which has no direct exposure to Russia through any of its investments.

Alongside its financial aims, the Fund has an explicit responsible investment policy, screening out areas of concern to many charities, integrating environmental, social and governance analysis as a fundamental part of its equity selection process and promoting best practice through active engagement. The managers invest to avoid harm, benefit society through responsible business activities and contribute to solutions through investing for impact. The investment managers will also use their influence to push for progress towards the Sustainable Development Goals.

Whilst there is no specific screen within the mandate to exclude Russian investments, given the fund’s overall aims, no Russian stocks were deemed appropriate for the strategy and in-line with the Responsible policy.

Investment Strategy

The investment objective is to be achieved by investment in a balanced portfolio, which can include equities, fixed interest securities and cash, with a medium risk profile. Exposure to hedge funds, structured investments and property funds will also be permissible. Trustees have taken advice and rely on an approach to provide real returns on funds , but avoiding High Risk / High Yield (Casino) patterns of investment, in line with responsible charitable organisation strategy.

Investments Policy

Review

In order to monitor progress of the performance of the Association’s investments against this policy Cazenove Capital Management wealth management from Schroders provides valuation reports six monthly on 30 June and 31 December. Figures showing the capital performance and a range of indices including the APCIMS Balanced Index are included within these valuation reports.

The trustees will periodically consider whether there is a need to revise the Investment Strategy.

In 2023, the portfolio increased in value by 2.5% to £1,386,998, (2022: decrease 10.3% to £1,352,999). The income being generated by the investments increased by 4.6% to £72,937 (2022: 6% to £69,740) and is derived from a combination of exposure to high yielding equities as well as the fixed interest area of the market.

- 18 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2023

PLANS FOR FUTURE PERIODS

BAOMS Annual Scientific Meeting (ASM) 3-5 July 2024, Oxford Hosted by BAOMS 62[nd] President Miss Daljit K Dhariwal

The BAOMS Annual Scientific Meeting will be held at the Oxford Mathematical Institute, 3rd - 5th July 2024. The theme of the meeting is the Patients’ Voice with patients on discussion panels throughout the meeting. There are plans one pre-conference SORG course at the Oxford anatomy department. The Mathematical Institute is close to the city centre with several hotels and Oxford Colleges offering accommodation nearby. All the social events will be within 10 minutes walking distance of this venue. The Welcome reception will be held at Oxford‘s Natural History Museum a beautiful Gothic building. The Gala dinner will be held at Oxford Town Hall. There will be three parallel educational events running alongside the ASM. On Wednesday, our SAS colleagues have organised an excellent programme of speakers aimed at their specific educational needs. On Thursday, the Maxillofacial Prosthetists will run a similar all day programme and there will be a parallel Nurses day on Friday.

Ilankovan About Face Fund

In 2024, the Charity About Face transferred funds to BAOMS to be managed as a restricted grant named “Ilankovan About Face Grant", in such amount(s) to be decided by the Endowment sub-committee of BAOMS, to be awarded to Fellows/ Members of BAOMS in order to support Head & Neck Cancer research projects, subject to suitable applications being received. Although the funds were transferred and received by BAOMS in 2024, they met the criteria for income recognition in 2023 and so have been accrued as at 31 December 2023.

BAOMS Council Strategy Day

In November 2023 there was a BAOMS strategy day and outcomes are planned to be reported during 2024.

These financial statements were approved the members of the committee on 22[nd] April 2024 and are signed on their behalf by:

President Miss Daljit K Dhariwal

Honorary Treasurer Mr Robert J Banks

- 19 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2023

Opinion

We have audited the financial statements of The British Association of Oral and Maxillofacial Surgeons (the ‘charitable company’) for the year ended 31 December 2023 which comprise the statement of financial activities, the balance sheet, and statements of cash flows, the principal accounting policies and the notes to the financial statements. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

- 20 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2023

Other information (continued)

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

- 21 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2023

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

We assessed the susceptibility of the charity’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

- 22 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2023

Auditor’s responsibilities for the audit of the financial statements (continued)

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

As a result of our procedures we did not identify any key audit matters relating to irregularities.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the trustees and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of this report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Catherine Biscoe Senior Statutory Auditor For and on behalf of Buzzacott LLP Statutory Auditor 130 Wood Street London EC2V 6DL

Date: 30 April 2024

- 23 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING THE INCOME AND EXPENDITURE ACCOUNT)

YEAR ENDED 31 DECEMBER 2023

Unrestricted Restricted Total Total
Funds Funds Funds 2023 Funds 2022
£ £ £ £
Note
INCOME FROM
Donations 16 - 397,965 397,965 -
Investments 2 72,937 - 72,937 69,740
Charitable activities 3 734,383 - 734,383 793,065
-------------------------------------- ------------------------------------ ------------------------------------ ------------------------------------
TOTAL INCOME 807,320 397,965 1,205,285 862,805
--------------------------------------- ----------------------------------- ------------------------------------ ------------------------------------
EXPENDITURE ON
Raising Funds
Investments 4 12,433 - 12,433 15,459
Charitable activities 937,620 180 937,800 927,612
------------------------------------- --------------------------------- ------------------------------------ ------------------------------------
TOTAL EXPENDITURE 950,053 180 950,233 943,071
-------------------------------------- ------------------------------ ------------------------------------ ------------------------------------
NET EXPENDITURE
FOR THE YEAR
BEFORE GAINS,
(LOSSES)ON
INVESTMENTS (142,733) 397,785 255,052 (80,266)
Net gains, (losses) on
investments 12 33,999 - 33,999 (154,635)
------------------------------------------- ------------------------------------------ ---------------------------------- ----------------------------------
NET (EXPENDITURE)
INCOME FOR THE YEAR
AND NET MOVEMENT IN
FUNDS (108,734) 397,785 289,051 (234,901)
RECONCILIATION OF
FUNDS
Total funds brought forward 1,471,028 105,169 1,576,197 1,811,098
----------------------------------------------- ------------------------------------ ----------------------------------------------- -----------------------------------------------
TOTAL FUNDS CARRIED
FORWARD 1,362,294 502,954 1,865,248 1,576,197
=============================================== ==================================== =============================================== ===============================================

All recognised gains and losses are included in the above statement of financial activities.

All of the above amounts relate to continuing activities.

The notes on pages 28-43 form part of these financial statements

- 24 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

COMPARATIVE STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2022

Unrestricted Restricted
Total

Total
Funds Funds
Funds 2022

Funds 2021
£ £ £ £
Note
INCOME FROM
Investments 2 69,740 - 69,740 65,771
Charitable activities 3 793,065 - 793,065 569,732
-------------------------------------- ------------------------------------ ------------------------------------ ------------------------------------
TOTAL INCOME 862,805 - 862,805 635,503
--------------------------------------- ----------------------------------- ------------------------------------ ------------------------------------
EXPENDITURE ON
Raising Funds
Investments 4 15,459 - 15,459 14,663
Charitable activities 5 927,297 315 927,612 706,392
------------------------------------- --------------------------------- ------------------------------------ ------------------------------------
TOTAL EXPENDITURE 942,756 315 943,071 721,055
-------------------------------------- ------------------------------ ------------------------------------ ------------------------------------
NET EXPENDITURE FOR
THE YEAR BEFORE
(LOSSES) GAINS ON
INVESTMENTS (79,951) (315)
(80,266)

(85,552)
Net (losses) gains on
investments 12 (154,635) - (154,635)
138,923
------------------------------------------- ------------------------------------------ ---------------------------------- ----------------------------------
NET (EXPENDITURE) INCOME
FOR THE YEAR AND NET
MOVEMENT IN FUNDS (234,586) (315)
(234,901)

53,371
RECONCILIATION OF FUNDS
Total funds brought forward 1,705,614 105,484 1,811,098 1,757,727
----------------------------------------------- ------------------------------------ ----------------------------------------------- -----------------------------------------------
TOTAL FUNDS CARRIED
FORWARD 1,471,028 105,169 1,576,197 1,811,098
=========================================== =========================================== ===========================================
==== ==================================== ==== ====

The notes on pages 28-43 form part of these financial statements

- 25 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

BALANCE SHEET

31 DECEMBER 2023

2023 2022
Note £ £ £
FIXED ASSETS
Intangible assets 11 14,064 21,096
Tangible assets 11 - -
Investments 12 1,386,998 1,352,999
----------------------------------------------- -----------------------------------------------
1,401,062 1,374,095
CURRENT ASSETS
Debtors 13 714,191 362,948
Cash in hand 60,900 113,026
------------------------------------ ------------------------------------
775,091 475,974
CREDITORS: Amounts falling due within one
year 14 (310,905) (273,872)
------------------------------------ ------------------------------------
NET CURRENT ASSETS 464,186 202,102
----------------------------------------------- -----------------------------------------------
NET ASSETS 1,865,248 1,576,197
=============================================== ===============================================
THE FUNDS OF THE CHARITY
Restricted funds 16 502,954 105,169
Unrestricted funds: General 17 539,032 236,116
Unrestricted funds: Designated 17 823,262 1,234,912
----------------------------------------------- -----------------------------------------------
TOTAL CHARITY FUNDS 1,865,248 1,576,197
=============================================== ===============================================

These financial statements were approved on 22nd April 2024 and signed by the member of the committee and are signed on their behalf by:

President Miss Daljit K Dhariwal Company Registration Number: 03337359

Honorary Treasurer Mr Robert J Banks

The notes on pages 28-43 form part of these financial statements

- 26 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

STATEMENT OF CASH FLOWS

YEAR ENDED 31 DECEMBER 2023

Note
CASH OUTFLOW FROM OPERATING ACTIVITIES
NET CASH USED IN OPERATING
ACTIVITIES
19
CASH INFLOW FROM INVESTING ACTIVITIES
Income from UK Listed Investments
Interest received
Net cash provided by investing activities
CHANGE IN CASH AND CASH EQUIVALENTS
IN THE YEAR
20
CASH AND CASH EQUIVALENTS
1 JANUARY
20
CASH AND CASH EQUIVALENTS
31 DECEMBER
20
2024
£
(125,063)
71,243
1,694
-----------------------------------------
----
72,937
------------------------------- -----
---
(52,126)
113,026

-----------------------------------------
60,900
2022
£
(190,571)
69,633
107
------------------------------------------
69,740
------------------------------------------
(120,831)
233,857
______
113,026

The notes on pages 28-43 form part of these financial statements

- 27 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

1. ACCOUNTING POLICIES

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are laid out below.

Basis of preparation

These financial statements have been prepared for the year to 31 December 2023.

The financial statements have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant accounting policies below or the notes to these financial statements.

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) (Charities SORP FRS 102) and the Companies Act 2006.

The charity constitutes a public benefit entity as defined by FRS 102.

The financial statements are presented in sterling and are rounded to the nearest pound.

Critical accounting estimates and areas of judgement

Preparation of the financial statements requires the trustees and management to make significant judgements and estimates.

The items in the financial statements where these judgements and estimates have been made include:

Assessment of going concern

The trustees have assessed whether the use of the going concern assumption is appropriate in preparing these financial statements. The trustees have made this assessment in respect to a period of one year from the date of approval of these financial statements. The trustees of the charity have concluded that, there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the charity to continue as a going concern.

- 28 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

Assessment of going concern (continued)

The Association will be running a number of well subscribed events in 2024 and anticipates a surplus and good levels of cash in 2024 despite increases in inflation, the current economic climate and cost of living challenges.

The Trustees have reviewed the risks posed to the charity and concluded that the group and the charity are in a strong financial and operational position and can continue to support beneficiaries now and for the foreseeable future.

The trustees are therefore of the opinion that the charity will have sufficient resources to meet its liabilities as they fall due.

With regard to the next accounting period, the year ending 31 December 2024, the most significant areas that affect the carrying value of the assets held by the charity are the level of investment return and the performance of the investment markets.

Income recognition

Income is recognised in the period in which the charity has entitlement to the income, the amount of income can be measured reliably, and it is probable that the income will be received.

Donations are recognised when the charity has confirmation of both the amount and settlement date. In the event of donations pledged but not received, the amount is accrued for where the receipt is considered probable.

Credit is taken in the statement of financial activities for the proportion of subscriptions which are receivable in the financial year. All other similar types of income are accounted for on an accruals basis.

In accordance with the Charities SORP FRS 102 volunteer time is not recognised.

Dividends are recognised once the dividend has been declared and notification of the dividend has been received.

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.

Expenditure recognition

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to make a payment to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis. Expenditure comprises direct costs and support costs. All expenses, including support costs, are allocated or apportioned to the applicable expenditure headings. The classification between activities is as follows:

- 29 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

Expenditure recognition (continued)

Grants payable are included in the statement of financial activities when approved and when the intended recipient has either received the funds or been informed of the decision to make the grant and has satisfied all performance conditions. Grants approved but not paid at the end of the financial year are accrued. Grants where the beneficiary has not been informed or has to fulfil performance conditions before the grant is released are not accrued for.

Irrecoverable VAT is included within support costs and allocated as detailed below.

Allocation of support and governance costs

Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the charity it is necessary to provide support in the form of personnel development, financial procedures, provision of office services and equipment and a suitable working environment.

Governance costs comprise the costs involving the public accountability of the charity including audit costs) and costs in respect to its compliance with regulation and good practice.

Support costs including staff costs and governance costs are apportioned based on the proportion used by the activity.

Intangible fixed assets

All assets costing more than £5,000 and with an expected useful life exceeding one year are capitalised. Amortisation is provided over a period of 5 years, based on the estimated useful life of the asset, on a straight line basis.

Tangible fixed assets

All assets costing more than £5,000 and with an expected useful life exceeding one year are capitalised.

Expenditure on the purchase and replacement of furniture and equipment is capitalised and depreciated over a 4–10-year period, based on the estimated useful life of the asset, on a straight line basis.

- 30 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

Fixed asset investments

Listed investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price.

The charity does not acquire put options, derivatives or other complex financial instruments.

Realised gains (or losses) on investment assets are calculated as the difference between disposal proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. Unrealised gains and losses are calculated as the difference between the fair value at the year end and their carrying value at that date. Realised and unrealised investment gains (or losses) are combined in the statement of financial activities and are credited (or debited) in the year in which they arise.

Debtors

Debtors are recognised at their settlement amount, less any provision for non-recoverability. Prepayments are valued at the amount prepaid.

Cash at bank and in hand

Cash at bank and in hand represents such accounts and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.

Creditors and provisions

Creditors and provisions are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Creditors and provisions are recognised at the amount the charity anticipates it will pay to settle the debt.

Operating lease agreements

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profits on a straight line basis over the period of the lease.

Pension costs

The charitable company participates in a multi-employer defined benefit pension scheme known as Superannuation Arrangements of the University of London (''SAUL''). The scheme is contracted out of the State Earnings-Related Pension Scheme, and is a centralised scheme for certain employees with the assets held in separate trustee-administered funds. The charitable company is unable to identify its share of the underlying assets and liabilities of the scheme.

The amount charged to the statement of financial activities in respect of pension costs is the total contributions payable for the year.

- 31 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

Fund Structure

The general fund comprises the accumulated surpluses of unrestricted income over expenditure, which are available for use in furtherance of the general objectives of the charitable company.

Designated funds are a particular form of unrestricted funds consisting of amounts, which have been allocated or designated for specific purposes by the trustees. The use of designated funds remains at the discretion of the trustees.

Restricted funds are funds subject to specific conditions imposed by donors. The purpose and use of the funds are set out in the notes to the accounts. Amounts unspent at the year-end are carried forward in the balance sheet.

- 32 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

2. INCOME FROM INVESTMENTS

Income from UK listed investments
Bank interest receivable
UnrestrictedFunds
Total Funds
2023
Total Funds
2022
£
£
71,243
69,633
1,694
107
-------------------------------
-------------------------------
72,937
69,740
===============================
===============================

3. INCOME FROM CHARITABLE ACTIVITIES

Unrestricted Restricted Total Total
Funds Funds Funds Funds
2023 2022
£ £ £ £
Subscription income from members 167,754 - 167,754 168,624
Journal income 330,676 - 330,676 365,249
Annual scientific meeting income 235,953 - 235,953 259,192
-------------------------------- -------------------------------- -------------------------------- --------------------------------
734,383 - 734,383 793,065
========================-================ ==================================== ======================================== ========================================

During the year ended 31 December 2023 the Annual Scientific Meeting recorded a deficit of £3,197, (income £235,953). During the year ended 31 December 2022 the Annual Scientific Meeting generated a surplus of £47,496 (income £259,192) due to the recognition of sunk costs on deferral of the event.

Unrestricted Restricted Total Funds
Funds Funds 2022
£ £ £
Subscription income from members 168,624 - 168,624
Journal income 365,249 - 365,249
Annual scientific meeting income 259,192 - 259,192
-------------------------------- -------------------------------- --------------------------------
793,065 - 793,065
========================-=== ==================================== ========================================

- 33 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

4. INVESTMENT MANAGEMENT COSTS

----- Start of picture text -----
|||| |---|---|---| |Unrestricted Funds| |Total Funds|Total Funds| |2023|2022| |£|£| |Investment management fees|12,433|15,459|

----- End of picture text -----

5. EXPENDITURE ON CHARITABLE ACTIVITIES

----- Start of picture text -----
|||||| |---|---|---|---|---| |Unrestricted|Restricted|Total Funds|Total Funds| |Funds|Funds|2023|2022| |£|£|£|£| |Grants awarded (note 7)|42,856|-|42,856|76,834| |Costs of disseminating information| |on the speciality|675,783|180|675,963|632,329| |Support costs (note 6)|218,981|-|218,981|218,449| |-----------------------------------|---------------------------------|--------------------------------------|--------------------------------------| |937,620|180|937,800|927,612| |========================================|=======================================|====================================|====================================| |Unrestricted|Restricted|Total Funds| |Funds|Funds|2022| |£|£|£| |Grants awarded (note 7)|76,834|-|76,834| |Costs of disseminating information| |on the speciality|632,014|315|632,329| |Support costs (note 6)|218,449|-|218,449| |-----------------------------------|---------------------------------|--------------------------------------| |927,297|315|927,612| |====================================== ==================================== ====================================|

----- End of picture text -----

6. SUPPORT COSTS

----- Start of picture text -----
|||| |---|---|---| |Unrestricted Funds| |Total Funds|Total Funds| |2023|2022| |£|£| |Salaries and wages|130,290|119,204| |Communications costs|3,048|1,216| |Audit fees|10,250|9,470| |Rent|13,999|11,702| |Bookkeeping|11,515|11,151| |Finance costs|9,161|8,453| |Irrecoverable VAT expense|35,118|45,219| |Other office costs|5,600|12,034| |------------------------------------|------------------------------------| |218,981|218,449| |=====================-===============|=====================-===============|

----- End of picture text -----

- 34 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

7. ANALYSIS OF GRANTS

ANALYSIS OF GRANTS
2023 2022
£ £
Grants to individuals
Research grants awarded to one individual (2022: two) 3,710 22,252
Travel electives and mini grants awarded to twenty five individuals.
(2022: fourteen) 13,870 21,157
Student bursaries awarded to thirty one individuals (2022: thirty-
four) 34,250 32,000
Poster prizes awarded to five individuals (2022: five) 900 800
Prizes to members
President's prize awarded to two individuals (2022:one) 1,000 500
Norman Rowe clinical prize to one individual (2022: two) 500 1000
Paul Toller research prize 500 500
BAOMS surgery prize 700 700
BAOMS members prize awarded to one individual (2022: one) 500 500
Down surgical prize awarded to one individual (2022: two) 1,000 2,000
Trainer of the year awarded to one individual (2022: none) 250 -
Associate fellows prize awarded to one individual (2022: none) 500 -
Returned or cancelled awards (23,000) (17,072)
------------------------------ ------------------------------
34,680 64,337
Speakers educational fund expenditure 8,176 12,497
------------------------------ ------------------------------
Total grants 42,856 76,834
=============================== ====================================

8. NET EXPENDITURE FOR THE YEAR BEFORE (LOSSES) GAINS ON INVESTMENTS

This is stated after charging:

2023 2022
£ £
Staff costs (note 9) 130,290 119,204
Auditors’ remuneration 10,250 9,470
Operating lease rentals 13,999 11,702
Depreciation 7,032 7,032
=============================== ===============================

- 35 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

9. STAFF COSTS, TRUSTEES EXPENSES AND REMUNERATION OF KEY MANAGEMENT PERSONNEL

Total staff costs were as follows:

Total staff costs were as follows:
2023 2022
£ £
Wages and salaries 102,350 96,327
Social security costs 6,552 5,824
Other pension costs 21,388 17,053
------------------------------------- -------------------------------------
130,290 119,204
==================================== ====================================

The key management personnel of the charity in charge of controlling, running and operating the charity on a day to day basis comprise the trustees, the Chairman of the Council and the Senior Administrator.

The total remuneration (including taxable benefits and pension contributions) paid to key management personnel for the year was £93,427 (2022: £86,582).

One Officer of the Council received £28,429 (2022: one Officer: £27,022) for services as Council members provided to the Association. No trustees received any remuneration for their services as trustees. During the year, Council members were reimbursed for travel expenses incurred in attending Council and other relevant meetings totalling £24,453 (2022: £10,216), of which five (2022: six) trustees received £18,060 (2022: £6,760).

The charity has taken out a public liability insurance policy that provides professional indemnity cover (amounting to £500,000 in respect of any one claim) for the Council members (including the trustees) and staff of the charity. The cost of this insurance policy to the charity for the year was £1,548 (2022: £1,483).

Particulars of employees:

The average number of employees during the year:

The average number of employees during the year:
2023 2022
No. No.
Office and administration staff 2 2
Editorial staff - -
-------------- --------------
2 2
-=============== ================

One employee earned remuneration of more than £60,000 and less than £70,000 (including taxable benefits but excluding employer’s pension contributions) during the year (2022: one).

10. TAXATION

The British Association of Oral Maxillofacial Surgeons is a registered charity and therefore is not liable to income tax or corporation tax on income or gains derived from its charitable activities, as they fall within the various exemptions available to registered charities.

- 36 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

11. FIXED ASSETS
Intangible Office Computer
assets equipment equipment
Total
£ £ £ £
COST
At 1 January 2023 35,160 8,261 16,019 59,440
Additions - - - -
------ ---------------------- ---------------------------- -------------------------------- --------------------------------
At 31 December 2023 35,160 8,261 16,019 59,440
========================== =============================== =============================== ===============================
DEPRECIATION AND AMORTISATION
At 1 January 2023 14,064 8,261 16,019 38,344
Charge for the year 7,032 - - 7,032
-------------------------- -------------------------- ------------------------------- -------------------------------
At 31 December 2023 7,032 8,261 16,019 45,376
========================== ========================== =============================== ===============================
NET BOOK VALUE
At 31 December 2023 14,064 - - 14,064
========================== ========================== ========================== ==========================
At 31 December 2022 21,096 - - 21,096
========================== ========================== ========================== ===============================
12. INVESTMENTS
Movement in market value
2023 2022
£ £
Market value at 1 January 1,352,999 1,507,634
Net unrealised gains, (losses) 33,999 (154,635)
----------------------------------------------- -----------------------------------------------
Market value at 31 December 1,386,998 1,352,999
=============================================== ===============================================
Historical cost at 31 December 1,193,235 1,193,235
=============================================== ====================================
2023 2022
£ £
Quoted investments
Alternative (UK) 1,386,998 1,352,999
----------------------------------------------- -----------------------------------------------
1,386,998 1,352,999

As at 31 December 2023 and 31 December 2022, all holdings were within Schroder Charity Responsible Multi Asset Funds.

- 37 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

13. DEBTORS

Trade debtors
Other debtors
Prepayments
Accrued income
-

CREDITORS: Amounts falling due within one year
Trade creditors
Taxation and social security
Unpaid awards, grants and prizes
Accruals
Deferred income



Deferred Income
Deferred income brought forward
Income deferred in the current year
Deferred income released in the current year
Deferred income carried forward
2023
2022
£
£
76,089
18,360
-
4,792
240,137
339,796
397,965
-
-------------------------------------
--------------------------------------
714,191
362,948
====================================
====================================
2023
2022
£
£
3,045
28,287
8,259
3,703
53,575
69,902
82,701
67,001
163,325
104,979
------------------------------------
------------------------------------
310,905
273,872
====================================
====================================
2023
2022
£
£
81,179
130,880
82,825
81,179
(81,179)
(130,880)
163,325
104,979

14. CREDITORS: Amounts falling due within one year

Deferred income relates to subscription income and meeting income in advance.

15. COMMITMENTS UNDER OPERATING LEASES

At 31 December the charity had future minimum commitments under non-cancellable operating leases as set out below:

Land and buildings Land and buildings
2023 2022
Payments which fall due: £ £
Within one year 13,896 15,934
Within 2 to 5 years 10,422 37,922
Greater than 5 years -
---------------------------------- ----------------------------------
24,318 35,024
-================================ ===============================

- 38 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2023

16. RESTRICTED INCOME FUNDS

Year ended 31 December Balance at Balance at
2021 1 Jan 2023 Income Expenditure 31 Dec 2023
£ £ £ £
e Learning Fund 89,041 - - 89,041
Norman Rowe Fund 13,303 - (180) 13,123
Map of Medicine 2,825 - - 2,825
Ilankovan About Face Fund - 397,965 - 397,965
------------------------------------ ------------------------------------ ------------------------------------ ------------------------------------
105,169 397,965 (180) 502,954
==================================== ==================================== ==================================== ====================================

The e Learning Fund was set up in 2009 following the receipt of funding from the Department of Health to cover the costs incurred by BAOMS in relation to the e Learning project as it relates to the charity's specialty.

The Norman Rowe International Educational Foundation Fund was set up in 2007 following the receipt of a donation from the Norman Rowe Educational Trust which has become a subcommittee of the charity known as the Norman Rowe International Education Foundation (NRIEF). The funds are used to promote the oral and maxillofacial specialist needs of developing and post conflict countries.

The Map of Medicine Fund was set up in 2009 to recognise specific sponsorship income contributing to the costs of the Map of Medicine project work.

The Ilankovan About Face fund was set up following the receipt of a donation from the About Face charity. The funds are managed by the BAOMS Endowments Sub Committee and used for supporting head and neck cancer research in the widest sense.

Year ended 31 December Balance at Balance at
2021 1 Jan 2022 Income Expenditure 31 Dec 2022
£ £ £ £
e Learning Fund 89,041 - - 89,041
Norman Rowe Fund 13,618 - (315) 13,303
Map of Medicine 2,825 - - 2,825
------------------------------------ ------------------------------------ ------------------------------------ ------------------------------------
105,484 - (315) 105,169
==================================== ==================================== ==================================== ====================================

- 39 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2023

17. UNRESTRICTED INCOME FUNDS

Year ended 31 Balance at Gains and Balance at
December 2021 1 Jan 2023 Income Expenditure Transfers losses 31 Dec 2023
£ £ £ £ £ £
Designated
Research Fund 1,234,912 59,808 - (500,000) 28,542 823,262
General Funds 236,116 747,512 (950,053) 500,000 5,457 539,032
-------------------------------------------------- --------------------------------------- -------------------------------------- -------------------------------------- --------------------------------- --------------------------------------------------
1,471,028 807,320 (950,053) - 33,999 1,362,294
=============================================== ==================================== ==================================== ==================================== =============================== ===============================================

The Designated Research Fund was set up by the trustees in 2005 by a transfer of £500,000 from the General Fund. These funds have been invested and will be used to provide further research and educational grants to promote wider research in the speciality. The Trustees made the decision during the year ended 31 December 2023 to release designated funds that were held surplus to requirements, and so £500,000 was transferred from the Designated Research Fund to the General Fund.

Year ended 31
Balance at
Gains and Balance at
December 2022 1 Jan 2022 Income Expenditure losses 31 Dec 2022
£ £ £ £ £
Designated
Research Fund 1,299,684 53,061 - (117,833)
1,234,912
General Funds 405,930 809,744 (942,756) (36,802)
236,116
-------------------------------------------------- --------------------------------------- -------------------------------------- --------------------------------- --------------------------------------------------
1,705,614 862,805 (942,756) (154,635)
1,471,028
======================================= ==================================== ==================================== =============================== ======================================

18. ANALYSIS OF NET ASSETS BETWEEN FUNDS

At 31 December 2023 Intangible Net current
fixed assets Investments
assets

Total
£ £ £ £
Restricted Funds -
-
502,694 502,694
Unrestricted Funds 14,064 1,386,998 -38,768 1,362,294
----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
Total Funds 14,064
1,386,998
463,186 1,864,248
=============================================== =============================================== =============================================== ===============================================
At 31 December 2022 Intangible Net current
fixed assets
Investments

assets

Total
£ £ £ £
Restricted Funds - 105,169 105,169
Unrestricted Funds 21,096 1,352,999 96,933 1,471,028
----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
Total Funds 21,096
1,352,999
202,102 1,576,197
==================================== ==================================== ==================================== ====================================

- 40 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2023

18. ANALYSIS OF NET ASSETS BETWEEN FUNDS (CONTINUED)

Total unrealised gains as at 31 December 2023 constitute movements on revaluation and are as follows:

2023 2022
£ £
Unrealised gains included above:
On investments 194,033 160,034
------------------------------------- -------------------------------------
Total unrealised gains at 31 December 33,999 160,034
===================================== =====================================
Reconciliation of movements on unrealised gains:
Unrealised gains at 1 January 160,034 314,399
Add: Net gains, (losses) arising on revaluations in the year 33,999 (154,635)
--------------------------------------- ---------------------------------------
Total unrealised gains at 31 December 194,033 160,034
============================================= =============================================

19. RECONCILIATION OF NET INCOME TO NET CASH USED IN OPERATING ACTIVITIES

2023 2022
£ £
Net movement in funds (as per the statement of
financial activities) 289,051 (234,901)
Depreciation 7,032 7,032
Income from investments (71,243)
(69,633)
Interest receivable (1,694)
(107)
(Gains), losses on investments (33,999)
154,635
Increase in debtors (351,243)
(37,140)
Increase, (decrease) in creditors 37,033 (10,457)
------------------------------------- -------------------------------------
Net cash used in operating activities (125,063)
(190,571)
=============== ===============

20. ANALYSIS OF CHANGES IN NET DEBT

1 Jan 23 Cash flows 31 Dec 23
£ £ £
Cash in hand and at bank 113,026 (52,126) 60,900
==================================== ========================================== ========================================

- 41 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2023

21 . PENSION SCHEME

The Association participates in the Superannuation Arrangements of the University of London (“SAUL”), which is a centralised defined benefit scheme within the United Kingdom and was contracted out of the Second State Pension (prior to April 2016).

SAUL is an independently managed pension scheme for the non-academic staff of over 50 colleges and institutions with links to higher education.

Pension benefits accrued within SAUL currently build up on a Career Average Revalued Earnings (“CARE”) basis.

The Association is not expected to be liable to SAUL for any other current participating employer’s obligations under the Rules of SAUL, but in the event of an insolvency of any participating employer within SAUL, an amount of any pension shortfall (which cannot otherwise be recovered) in respect of that employer, may be spread across the remaining participating employers and reflected in the next actuarial valuation.

Funding Policy

SAUL’s statutory funding objective is to have sufficient and appropriate assets to meet the costs incurred by the Trustee in paying SAUL’s benefits as they fall due (the “Technical Provisions”). The Trustee adopts assumptions which, taken as a whole, are intended to be sufficiently prudent for pensions and benefits already in payment to continue to be paid and for the commitments which arise from Members’ accrued pension rights to be met.

The Technical Provisions assumptions include appropriate margins to allow for the possibility of events turning out worse than expected. However, the funding method and assumptions do not completely remove the risk that the Technical Provisions could be insufficient to provide benefits in the future.

A formal actuarial valuation of SAUL is carried out every three years by a professionally qualified and independent actuary. The last actuarial valuation was carried out with an effective date of 31 March 2020. Informal reviews of SAUL’s position, reflecting changes in market conditions, cash flow information and new accrual of benefits, are carried out between formal valuations.

The funding principles were agreed by the Trustee and employers in June 2021 and will be reviewed again at SAUL’s next formal valuation in 2023.

At the 31 March 2020 valuation SAUL was 94% funded on its Technical Provisions basis. However, market movements following the valuation date were positive and the Trustees and the Employers agreed to allow for post-valuation experience up to 30 April 2021. As SAUL was in surplus on its Technical Provisions basis at that date, no deficit contributions were required.

However, the Trustee and the Employers have agreed that the ongoing Employers’ contributions will increase from a rate of 16% of CARE Salaries to 19% of CARE Salaries from 1 April 2022 and to 21% of CARE Salaries from 1 January 2023.

Employer pension contributions charged to the statement of financial activities during the year amounted to £21,388 (2022: £17,053).

- 42 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2023

21 . PENSION SCHEME (CONTINUED)

Accounting Policy

The Association is a Participating Employer in SAUL. The actuarial valuation applies to SAUL as a whole and does not identify surpluses or deficits applicable to individual employers. As a whole, the market value of SAUL’s assets at 31 March 2020 was £3,612 million representing 94% of the liabilities. The market value of SAUL’s assets at 30 April 2021 was £4,369 million representing 109% of the estimated liabilities.

It is not possible to identify an individual Employer’s share of the underlying assets and liabilities of SAUL. The Association accounts for its participation in SAUL as if it were a defined contribution scheme and pension costs based on the amounts actually paid (i.e cash amounts) in accordance with paragraphs 28.11 of FRS 102.

Although there was a Technical Provisions deficit at 31 March 2020, allowing for post valuation experience to 30 April 2021, SAUL had a Technical Provisions surplus. Therefore, no deficit contributions were required following the 2020 valuation and there is no defined benefit liability (i.e the present value of any deficit contributions due to SAUL) to be recognised by the Association.

22 . RELATED PARTY TRANSACTIONS

One Officer of Council received £35,537, (2022: one Officer received £27,022) for services as Council members provided to the Association. No trustees received any remuneration for their services as trustees. During the year, Council members were reimbursed for travel and subsistence expenses incurred or paid for by the charity on their behalf in attending Council and other relevant meetings totalling £26,407, (2022: £10,216), of which five (2022: six) trustees received £20,014 (2022: £6,760).

During the year ended 31[st] December 2023, the Association was invoiced £3,595 (2022: £1,600) by S Brennan for graphic design services. S Brennan is the spouse of the Association’s Senior Administrator who is also a member of the key management personnel. At the year end the Association owed S Brennan £nil, (2022: £520). The transactions were made on terms equivalent to those that prevail in arm’s length transactions.

Prizes awarded during the year included the Down Surgical Prize, this prize, of £1,000 was awarded to P Brennan (Chair of Council) in 2022 (presented in 2023) and BAOMS Surgery Prize 2022 (presented in 2023) £700 was awarded to B Bisase.

- 43 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2023

The following pages do not form part of the statutory financial statements which are the subject of the independent auditor's report

- 44 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

DETAILED STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2023

2023 2022
£ £
INCOME FROM DONATIONS
Donations 397,965 -
INCOME FROM
INVESTMENTS
Income from UK listed investments 71,243 69,633
Bank interest receivable on short term cash deposits 1,694 107
------------------------------------ ------------------------------------
72,937 69,740
------------------------------------ ------------------------------------
CHARITABLE ACTIVITIES
Subscription income from members 167,754 168,624
Journal income 330,676 365,249
Annual scientific meeting income 235,953 259,192
------------------------------------ ------------------------------------
734,383 793,065
------------------------------------ ------------------------------------
------------------------------------ ------------------------------------
TOTAL 1,205,285 862,805
------------------------------------ ------------------------------------
EXPENDITURE ON
INVESTMENT MANAGEMENT COSTS
Investment management fees 12,433 15,459
-------------------------------------- ------------------------------------

- 45 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

DETAILED STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2023

2023 2022
£ £
CHARITABLE ACTIVITIES
Staff costs - Wages & Salaries 102,350 96,327
Staff costs - Employer's NIC 6,552 5,824
Staff costs - Pension costs 21,388 17,053
Establishment - Rent 13,999 11,702
Amortisation 7,032 7,032
JTG conference costs and JT (MRCS) programme 28,960 6,040
Website development and maintenance costs 8,301 6,843
AAOMS/Overseas BAOMS Presidents 14,281 14,257
Strategic costs / PR Officer 3,167 12,140
Grants, awards and prizes 42,856 76,834
Cost of providing journals to members 158,861 161,355
Annual Scientific Meeting expenditure 239,150 211,696
Committee, council and senate expenses 38,081 38,308
Chairman of council and deputy chair costs 35,537 27,022
Presidents annual fund 35,090 12,838
Other office costs 5,600 12,034
Irrecoverable VAT expense 35,118 45,219
Bookkeeping 11,515 11,151
Communications 3,048 1,216
Bank interest and charges 9,161 8,453
Audit fees 10,250 9,070
Audit advisory fees - 400
QOMS 84,875 106,238
BAOMS membership operating system 15,779 16,977
Publications 6,850 11,583
------------------------------------ ------------------------------------
937,800 927,612
------------------------------------ ------------------------------------
------------------------------------ ------------------------------------
NET EXPENDITURE FOR THE YEAR 255,052 (80,266)
BEFORE GAINS ON INVESTMENTS =================================== =================== ================

- 46 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

DETAILED STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2023

2023 2022
£ £
CHARITABLE ACTIVITIES
Costs of disseminating information on the
speciality
Activities undertaken directly
JTG conference costs and JT (MRCS) programme 28,960 6,040
ASiT 3,000 6,000
OMFS Illustrated guide 3,850 5,583
Amortisation 7,032 7,032
Website development and maintenance costs 8,301 6,843
QOMS 84,875 106,238
Strategic costs/ PR Officer 3,167 12,140
Cost of providing journals to members 158,861 161,355
Annual Scientific Meeting expenditure 239,150 211,696
Committee, council and senate expenses 38,081 38,308
Chairman of council and deputy chair costs 35,537 27,022
Presidents annual fund 35,090 12,838
BAOMS membership operating system 15,779 16,977
AAOMS/Overseas BAOMS Presidents 14,281 14,257
Grants, awards and prizes 42,856 76,834
------------------------------------ ------------------------------------
718,820 709,163
------------------------------------ ------------------------------------
Support costs
Staff costs - Wages & Salaries 102,350 96,327
Staff costs - Employer's NIC 6,552 5,824
Staff costs - Pension costs 21,388 17,053
Establishment - Rent 13,999 11,702
Other office costs 5,600 12,034
Irrecoverable VAT expense 35,118 45,219
Bookkeeping 11,515 11,151
Communications 3,048 1,216
Bank interest and charges 9,161 8,453
Audit fees 10,250 9,070
Audit advisory fees - 400
------------------------------------ ------------------------------------
218,981 218,449
------------------------------------ ------------------------------------
937,800 927,612
=================================== =================== ================

- 47 -